13C Magnetic Resonance Spectroscopy Studies of Alterations in Glutamate Neurotransmission

Biological Psychiatry

Volumn 59, Issue 10, 2006, Pages 883-887

  Shen, Jun ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

acetate metabolism; GABA; glucose metabolism; Glutamate glutamine cycle; in vivo 13C magnetic resonance spectroscopy

Indexed keywords

4 AMINOBUTYRIC ACID; GLUTAMIC ACID; IONOTROPIC RECEPTOR; METABOTROPIC RECEPTOR ANTAGONIST; PHENELZINE; ALPHA KETOGLUTAMIC ACID; ALPHA-KETOGLUTAMIC ACID; GLUTAMIC ACID DERIVATIVE; GLUTAMINE; METABOTROPIC RECEPTOR;

4 AMINOBUTYRIC ACID BRAIN LEVEL; 4 AMINOBUTYRIC ACID METABOLISM; ALZHEIMER DISEASE; CARBON NUCLEAR MAGNETIC RESONANCE; CELL MEMBRANE DEPOLARIZATION; EPILEPSY; EXCITOTOXICITY; GABAERGIC TRANSMISSION; GLIA CELL; GUINEA PIG; HIPPOCAMPUS; HUMAN; IN VIVO STUDY; NERVE CELL EXCITABILITY; NEUROMODULATION; NEUROPROTECTION; NEUROTRANSMISSION; NON INVASIVE MEASUREMENT; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RECEPTOR INTRINSIC ACTIVITY; REVIEW; SCHIZOPHRENIA; ARTICLE; BRAIN; GLIA; GLUCOSE BLOOD LEVEL; METABOLISM; NERVE CELL; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PHYSIOLOGY; SYNAPTIC TRANSMISSION;

BLOOD GLUCOSE; BRAIN; GAMMA-AMINOBUTYRIC ACID; GLUTAMATES; GLUTAMIC ACID; GLUTAMINE; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; NEUROGLIA; NEURONS; RECEPTORS, METABOTROPIC GLUTAMATE; SYNAPTIC TRANSMISSION;

EID: 33646205030     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biopsych.2005.07.042     Document Type: Review

References (62)

1. Attwell D., Barbour B., and Szatkowski M. Nonvesicular release of neurotransmitter. Neuron 11 (1993) 401-407
2. Behar K.L., and Rothman D.L. In vivo nuclear magnetic resonance studies of glutamate-gamma-aminobutyric acid-glutamine cycling in rodent and human cortex. The central role of glutamine. J Nutr 131 (2001) 2498S-2504S
3. Bender A., Auer D.P., Merl T., Reilmann R., Saemann P., Yassouridis A., et al. Creatine supplementation lowers brain glutamate levels in Huntington's disease. J Neurol 252 (2005) 36-41
4. Berkich D.A., Xu Y., LaNoue K.F., Gruetter R., and Hutson S.M. Evaluation of brain mitochondrial glutamate and alpha-ketoglutarate transport under physiologic conditions. J Neurosci Res 79 (2005) 106-113
5. Bordi F., and Ugolini A. Group I metabotropic glutamate receptors. Implications for brain diseases. Prog Neurobiol 59 (1999) 55-79
6. 13C glucose magnetic resonance spectroscopy of pediatric and adult brain disorders. NMR Biomed 14 (2001) 19-32
7. Bluml S., Moreno-Torres A., Shic F., Nguy C.H., and Ross B.D. Tricarboxylic acid cycle of glia in the in vivo human brain. NMR Biomed 15 (2002) 1-5
8. Burbaeva G.Sh., Boksha I.S., Turishcheva M.S., Vorobyeva E.A., Savushkina O.K., and Tereshkina E.B. Glutamine synthetase and glutamate dehydrogenase in the prefrontal cortex of patients with schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 27 (2003) 675-680
9. Cartmell J., and Schoepp D.D. Regulation of neurotransmitter release by metabotropic glutamate receptors. J Neurochem 75 (2000) 889-907
10. Chen Z., Silva A.C., Yang J., and Shen J. Elevated endogenous GABA level correlates with decreased fMRI signals in the rat brain during acute inhibition of GABA transaminase. J Neurosci Res 79 (2005) 383-391
11. 13C magnetic resonance spectroscopy. J Neurosci Res 66 (2001) 737-746
12. Conn P.J., and Pin J.P. Pharmacology and functions of metabotropic glutamate receptors. Annu Rev Pharmacol Toxicol 37 (1997) 205-237
13. 13C NMR studies of metabolic compartmentation in the adult mammalian brain. NMR Biomed 12 (1999) 451-462
14. Erecinska M., and Silver I.A. Metabolism and role of glutamate in mammalian brain. Prog Neurobiol 35 (1990) 245-296
15. 13C NMR studies of compartmentalized cerebral carbohydrate metabolism. Neurochem Int 41 (2002) 143-154
16. Gruetter R., Seaquist E.R., and Ugurbil K. A mathematical model of compartmentalized neurotransmitter metabolism in the human brain. Am J Physiol Endocrinol Metab 281 (2001) E100-E112
17. Hassel B., Johannessen C.U., Sonnewald U., and Fonnum F. Quantification of the GABA shunt and the importance of the GABA shunt versus the 2-oxoglutarate dehydrogenase pathway in GABAergic neurons. J Neurochem 71 (1998) 1511-1518
18. 13C] NMR spectroscopy. J Neurochem 82 (2002) 857-866
19. 13C NMR spectra using LCModel. NMR Biomed 16 (2003) 400-412
20. Hertz L. Functional interactions between neurons and astrocytes I. Turnover and metabolism of putative amino acid transmitters. Prog Neurobiol 13 (1979) 277-323
21. Hertz L. Intercellular metabolic compartmentation in the brain. Past, present and future. Neurochem Int 45 (2004) 285-296
22. Jackson M.F., Esplin B., and Capek R. Reversal of the activity-dependent suppression of GABA-mediated inhibition in hippocampal slices from γ-vinyl GABA (vigabatrin)-pretreated rats. Neuropharmacology 39 (2000) 65-74
23. 13C NMR spectroscopy. NMR Biomed 6 (1993) 264-277
24. 13C NMR for polarization of the carbonyl of oxaloacetate in the active site of citrate synthase. Biochemistry 24 (1985) 452-457
25. 13C nuclear magnetic resonance spectroscopy. Elucidation of the dominant pathway for neurotransmitter glutamate repletion and measurement of astrocytic oxidative metabolism. J Neurosci 22 (2002) 1523-1531
26. 13C MRS of rhesus monkey brain. Proc Intl Soc Magn Reson Med 13 (2005) 346
27. 13C magnetic resonance spectroscopy study. MAGMA 16 (2003) 29-42
28. Linden A.M., Greene S.J., Bergeron M., and Schoepp D.D. Anxiolytic activity of the MGLU2/3 receptor agonist LY354740 on the elevated plus maze is associated with the suppression of stress-induced c-Fos in the hippocampus and increases in c-Fos induction in several other stress-sensitive brain regions. Neuropsychopharmacology 29 (2004) 502-513
29. Linden A.M., Shannon H., Baez M., Yu J.L., Koester A., and Schoepp D.D. Anxiolytic-like activity of the mGLU2/3 receptor agonist LY354740 in the elevated plus maze test is disrupted in metabotropic glutamate receptor 2 and 3 knock-out mice. Psychopharmacology (Berl) 179 (2005) 284-291
30. Loscher W., and Horstermann D. Differential effects of vigabatrin, gamma-acetylenic GABA, aminooxyacetic acid, and valproate on levels of various amino acids in rat brain regions and plasma. Naunyn Schmiedebergs Arch Pharmacol 349 (1994) 270-278
31. Mason G.F., Gruetter R., Rothman D.L., Behar K.L., Shulman R.G., and Novotny E.J. Simultaneous determination of the rates of the TCA cycle, glucose utilization, alpha-ketoglutarate/glutamate exchange, and glutamine synthesis in human brain by NMR. J Cereb Blood Flow Metab 15 (1995) 12-25
32. Mason G.F., Rothman D.L., Behar K.L., and Shulman R.G. NMR determination of the TCA cycle rate and alpha-ketoglutarate/glutamate exchange rate in rat brain. J Cereb Blood Flow Metab 12 (1992) 434-447
33. Michael-Titus A.T., Bains S., Jeetle J., and Whelpton R. Imipramine and phenelzine decrease glutamate overflow in the prefrontal cortex-a possible mechanism of neuroprotection in major depression?. Neuroscience 100 (2000) 681-684
34. Moghaddam B., and Adams B.W. Reversal of phencyclidine effects by a group II metabotropic glutamate receptor agonist in rats. Science 281 (1998) 1349-1352
35. 13C-MRS to research on brain metabolism. NMR Biomed 16 (2003) 303-312
36. Morris P.G. Synaptic and cellular events. The last frontier?. Eur Neuropsychopharmacol 12 (2002) 601-607
37. Patel A.B., Rothman D.L., Cline G.W., and Behar K.L. Glutamine is the major precursor for GABA synthesis in rat neocortex in vivo following acute GABA transaminaseransaminase inhibition. Brain Res 919 (2001) 207-220
38. Pellerin L., Sibson N.R., Hadjikhani N., and Hyder F. What you see is what you think-or is it?. Trends Neurosci 24 (2001) 71-72
39. Petroff O.A., Errante L.D., Rothman D.L., Kim J.H., and Spencer D.D. Glutamate-glutamine cycling in the epileptic human hippocampus. Epilepsia 43 (2002) 703-710
40. 1H magnetic resonance spectroscopy in patients with epilepsy. J Cereb Blood Flow Metab 20 (2000) 871-878
41. 1H-NMR spectroscopy coupled with microdialysis. Exp Brain Res 127 (1999) 321-327
42. Popov N., and Matthies H. Some effects of monoamine oxidase inhibitors on the metabolism of gamma-aminobutyric acid in rat brain. J Neurochem 16 (1969) 899-907
43. Price N.C., and Stevens L. Fundamentals of Enzymology. 3rd ed. (2001), Oxford University Press, Oxford
44. 13C NMR spectroscopy and metabolomic study. J Neurochem 92 (2005) 405-416
45. 13C MRS in vivo. NMR Biomed 16 (2003) 358-369
46. Rothman D.L., Sibson N.R., Hyder F., Shen J., Behar K.L., and Shulman R.G. In vivo nuclear magnetic resonance spectroscopy studies of the relationship between the glutamate-glutamine neurotransmitter cycle and functional neuroenergetics. Philos Trans R Soc Lond B Biol Sci 354 (1999) 1165-1177
47. Sanacora G., Rothman D.L., Mason G., and Krystal J.H. Clinical studies implementing glutamate neurotransmission in mood disorders. Ann N Y Acad Sci 1003 (2003) 292-308
48. 13C]glucose metabolism. J Neurochem 61 (1993) 315-323
49. Shen J. Carbon-13 magnetization transfer spectroscopy. Detection of aspartate aminotransferase reaction in vivo (2005) Presentation #104 at the 22nd Annual Meeting of the European Society for Magnetic Resonance in Medicine and Biology, Basel, Switzerland
50. 13C NMR. Proc Natl Acad Sci U S A 96 (1999) 8235-8240
51. Shen J., and Rothman D.L. Magnetic resonance spectroscopic approaches to studying neuronal. Glial interactions. Biol Psychiatry 52 (2002) 694-700
52. 15N-NMR spectroscopy studies of ammonia transport and glutamine synthesis in the hyperammonemic rat brain. Dev Neurosci 20 (1998) 434-443
53. Shepherd G.M. Neurobiology. 3rd ed. (1994), Oxford University Press, New York
54. 13C NMR of intermediary metabolism. Implications for systemic physiology. Annu Rev Physiol 63 (2001) 15-48
55. 13C NMR measurements of cerebral glutamine synthesis as evidence for glutamate-glutamine cycling. Proc Natl Acad Sci U S A 94 (1997) 2699-2704
56. Sibson N.R., Dhankhar A., Mason G.F., Rothman D.L., Behar K.L., and Shulman R.G. Stoichiometric coupling of brain glucose metabolism and glutamatergic neuronal activity. Proc Natl Acad Sci U S A 95 (1998) 316-321
57. 13C NMR measurement of neurotransmitter glutamate cycling, anaplerosis and TCA cycle flux in rat brain during. J Neurochem 76 (2001) 975-989
58. Sibson N.R., Shen J., Mason G.F., Rothman D.L., Behar K.L., and Shulman R.G. Functional energy metabolism. In vivo 13C-NMR spectroscopy evidence for coupling of cerebral glucose consumption and glutamatergic neuronalactivity. Dev Neurosci 20 (1998) 321-330
59. Siesjo B.K. Brain Energy Metabolism (1978), John Wiley & Sons, Chichester, United Kingdom
60. Stryer L. Biochemistry. 4th ed. (1995), WH Freeman and Company, New York
61. 13C]D-glucose. Magn Reson Med 53 (2005) 1258-1267
62. Yang J, Shen J (in press): In vivo evidence for reduced cortical glutamate-glutamine cycling in rats treated with the antidepressant/antipanic drug phenelzine. Neuroscience.